RT Journal Article
SR Electronic
T1 Border closure and travel restrictions to control the spread of COVID-19: an update to a Cochrane review
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.22.22269686
DO 10.1101/2022.01.22.22269686
A1 Abou-Setta, Ahmed M.
A1 Lam, Otto LT
A1 Kasireddy, Viraj
A1 Askin, Nicole
A1 Tricco, Andrea C.
YR 2022
UL http://medrxiv.org/content/early/2022/01/25/2022.01.22.22269686.1.abstract
AB Background COVID-19 has proven to be more difficult to manage for many reasons including its high infectivity rate. One of the potential ways to limit its spread is by limiting free travel across borders, including via air travel. The objective of this systematic review is to identify, critically-appraise and summarize evidence on border closures and travel restrictions.Methods This review is based on the Cochrane review: “International travel-related control measures to contain the COVID-19 pandemic” and followed the same methodology. In brief, we searched for clinical and modelling studies in general health and COVID-19-specific bibliographic databases. The primary outcome categories were (i) cases avoided, (ii) cases detected, and (iii) a shift in epidemic development. Secondary outcomes were other infectious disease transmission outcomes, healthcare utilisation, resource requirements and adverse effects if identified in studies assessing at least one primary outcome.Results We included 43, mostly modelling, studies that met our inclusion criteria. Fourteen new studies were identified in the updated search, as well as updated companions (e.g., peer-reviewed publications that were previously only available as pre-prints). Most studies were of moderate to high quality. The added studies did not change the main conclusions of the Cochrane review nor the quality of the evidence (very low to low certainty). However, it did add to the evidence base for most outcomes.Conclusions Weak evidence supports the use of border closures to limit the spread of COVID-19 via air travel. Real-world studies are required to support these conclusions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding sources: World Health Organization and SPOR Evidence AllianceAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.